Send me real-time posts from this site at my email

Fresenius Medical and Vectren Receive Buy Ratings

Here are today's top Wall Street analyst ratings where's unbiased fair value estimates support the recommendation.

Top Upgrades and Buy Ratings

  • Citigroup upgraded Vectren Corp. (NYSE:VVC) from Neutral to Buy. Nine valuation models imply a fair value of $59 per share implying the stock is currently 13% undervalued.

Continue reading on our blog.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue